AngioWaveNet vs Salix Coronary Plaque

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 65/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.

AngioWaveNet

by Angiowave Imaging

Salix Coronary Plaque

by Artrya Limited

AI Verdict

AngioWaveNet enhances real-time fluoroscopic angiograms during cardiac catheterization procedures to improve vessel visualization. In contrast, Salix Coronary Plaque analyzes CCTA scans to quantify coronary artery plaque and stenosis for diagnostic purposes. While both leverage AI in cardiology, they address distinct needs within different imaging modalities and stages of patient care.

Choose AngioWaveNet if…

Choose AngioWaveNet if your primary need is to enhance the clarity and visibility of blood vessels during live fluoroscopic angiograms in the cardiac catheterization lab. This AI software seamlessly integrates with existing workflows, providing improved vessel visualization to support interventionalists in real-time procedures, regardless of the angiography system used.

View AngioWaveNet →

Choose Salix Coronary Plaque if…

Choose Salix Coronary Plaque if you require an AI-driven, near real-time assessment of coronary artery plaque and stenosis from CCTA scans for diagnostic purposes. This tool is ideal for identifying and quantifying plaque burden, including high-risk features, to aid in the accurate diagnosis of coronary artery disease and inform pre-procedural treatment planning.

View Salix Coronary Plaque →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature	AngioWaveNet	Salix Coronary Plaque
Pricing	Pricing options include annual software licensing or subscription-based access, tailored to cath lab volume and hospital needs. custom packages are available.	Contact for pricing
Deployment	Cloud-based or on-premise/servers	Cloud
FDA Status	1 AI-estimated	Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

AngioWaveNet

AngioWaveNet emphasizes seamless integration with existing Cath lab workflows, vendor-agnostic compatibility, and functions as a DICOM endpoint. It also highlights minimal training requirements and immediate processing of angiographic cines, allowing clinicians to review enhanced images almost instantly without delaying procedures.

Clinical Value

Salix Coronary Plaque

Salix Coronary Plaque provides a more comprehensive diagnostic assessment by detecting and quantifying coronary artery plaque, stenosis, and high-risk plaque features from CCTA scans. This detailed analysis directly aids in the rapid and accurate diagnosis and risk stratification of coronary artery disease.

Pricing & Value

Salix Coronary Plaque

Salix Coronary Plaque clearly outlines a per-scan assessment model with a stated US CPT reimbursement rate of US$950, offering a tangible and direct financial value proposition for adopting healthcare providers. AngioWaveNet's pricing is more general, based on annual licensing or subscription tailored to volume, without a specified reimbursement mechanism.

Enterprise Readiness

AngioWaveNet

AngioWaveNet offers flexible deployment options, including both cloud-based and on-premise/server installations, and is compatible with any fluoroscopic angiography system (vendor-agnostic). It is also explicitly HIPAA compliant, providing greater adaptability for diverse enterprise IT environments.

Innovation

Salix Coronary Plaque

Salix Coronary Plaque demonstrates higher innovation by leveraging AI for detailed, quantitative analysis and characterization of coronary plaque features and stenosis, including the identification of high-risk plaque characteristics. This provides a more advanced diagnostic capability compared to AngioWaveNet's focus on enhancing existing angiogram visualization.

Support & Docs

AngioWaveNet

AngioWaveNet explicitly states it provides 'full onboarding support, including installation assistance, staff training, and access to ongoing updates and clinical resources.' While Salix Coronary Plaque mentions a user guide, AngioWaveNet's detailed description of its support offerings suggests a more comprehensive and transparent approach to customer assistance.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature	AngioWaveNet	Salix Coronary Plaque
Name	AngioWaveNet	Salix Coronary Plaque
Company	Angiowave Imaging	Artrya Limited
Description	FDA-cleared AI software that enhances fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories, integrating with existing Cath lab workflows.	FDA-cleared, AI-driven, web-based software that provides near real-time, point-of-care assessment of coronary artery plaque and stenosis from CCTA scans, aiding in the rapid and accurate diagnosis of coronary artery disease.
Primary Application	Enhances fluoroscopic angiograms for improved vessel visualization	Assessment of coronary artery plaque and stenosis from CCTA scans
Key Features (Examples)	AI-powered Spatiotemporal Enhancement Processing (STEPu2122), Improved vessel visualization in fluoroscopic angiograms, Integrates with existing Cath lab workflows	AI-enabled CCTA analysis, Near real-time, point-of-care assessment, Detection and quantification of coronary plaque (atherosclerosis)

Videos

Demos, reviews, and walkthroughs featuring AngioWaveNet and Salix Coronary Plaque.

Loading videos…

Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

What types of cardiac imaging do AngioWaveNet and Salix Coronary Plaque analyze?

AngioWaveNet is designed to enhance fluoroscopic angiograms for improved vessel visualization in cardiac catheterization laboratories. Salix Coronary Plaque, on the other hand, analyzes CCTA (Coronary Computed Tomography Angiography) scans to assess coronary artery plaque and stenosis.

What are the primary clinical applications or benefits of each tool?

AngioWaveNet's primary application is to enhance the visibility of blood vessels, vascular structures, and anatomical features within angiographic images during X-ray coronary angiographic procedures, aiding in analysis and interpretation. Salix Coronary Plaque provides near real-time, point-of-care assessment for the detection and quantification of coronary plaque, identification of high-risk plaque features, and stenosis assessment from CCTA scans, assisting in the diagnosis of coronary artery disease.

How do these tools integrate into existing clinical workflows?

AngioWaveNet integrates with existing Cath lab workflows as a post-processing AI for angiographic images, compatible with any fluoroscopic angiography system and functioning as a DICOM endpoint. Salix Coronary Plaque is a web-based software that provides near real-time, point-of-care assessment with integrated workflow management and automated report generation, designed to integrate with existing imaging and patient management systems.

What specific analytical or enhancement features does each tool provide?

AngioWaveNet utilizes AI-powered Spatiotemporal Enhancement Processing (STEPu2122) to improve vessel visualization in fluoroscopic angiograms, enhancing the visibility of blood vessels, vascular structures, and anatomical features. Salix Coronary Plaque offers detection and quantification of coronary plaque, identification of high-risk plaque features (e.g., low-attenuation plaque, spotty calcification, positive remodeling, napkin-ring sign), stenosis assessment, and quantification of calcifications (calcium scoring).